Atorvastatin vs simvastatin
Pro Research Analysisby 
Searched over 200M research papers
Cholesterol-Lowering Efficacy: Atorvastatin vs Simvastatin
Multiple studies consistently show that atorvastatin is more effective than simvastatin at lowering total cholesterol, LDL cholesterol, triglycerides, and apolipoprotein B across a range of patient populations, including those with familial hypercholesterolemia, mixed dyslipidemia, and type 2 diabetes 1238. For example, atorvastatin 10 mg reduced LDL cholesterol by 37.2% compared to 29.6% with simvastatin 10 mg, and a higher percentage of patients reached LDL cholesterol goals with atorvastatin . In patients with severe familial hyperlipidemias, atorvastatin achieved target LDL levels more often than simvastatin-based therapies .
High-Dose Comparisons and HDL Cholesterol Effects
At higher doses, simvastatin has been shown to increase HDL cholesterol and apolipoprotein A-I more than atorvastatin, while atorvastatin provides slightly greater reductions in LDL cholesterol and triglycerides 510. For instance, simvastatin 80 mg increased HDL cholesterol by 8.3% compared to 4.2% with atorvastatin 80 mg, and this effect was consistent across patients with low HDL or metabolic syndrome . However, atorvastatin at maximum doses was associated with a higher incidence of drug-related gastrointestinal symptoms and liver enzyme elevations compared to simvastatin 510.
Safety and Adverse Events: Hepatotoxicity and Tolerability
Both statins are generally well tolerated, but high-dose atorvastatin is associated with a higher risk of significant hepatotoxicity compared to simvastatin, especially in the first six months of treatment 6710. The risk of moderate to severe liver dysfunction was notably higher with high-dose atorvastatin than with low-dose simvastatin . Most adverse events for both drugs were mild to moderate, and serious adverse events were rare 235.
Special Populations: Diabetes, Familial Hypercholesterolemia, and Depression
In patients with type 2 diabetes, atorvastatin was less effective than combination ezetimibe/simvastatin in lowering LDL cholesterol, but both treatments were well tolerated . For familial hypercholesterolemia, atorvastatin was more effective at achieving LDL cholesterol targets than simvastatin 18. Interestingly, in post-coronary artery bypass graft patients with mild to moderate depression, simvastatin showed superior antidepressant effects compared to atorvastatin, though the study was small and short-term .
Cost-Effectiveness
High-dose atorvastatin is considered cost-effective compared to regular-dose simvastatin for secondary prevention of cardiovascular events, particularly in high-risk patients, though the cost-effectiveness depends on the price difference between the two drugs .
Conclusion
Atorvastatin generally provides greater reductions in LDL cholesterol, total cholesterol, and triglycerides than simvastatin, making it more effective for achieving lipid-lowering goals in most patients. However, simvastatin may be preferable for patients needing greater increases in HDL cholesterol or those at higher risk for liver-related side effects. Both drugs are well tolerated, but high-dose atorvastatin carries a higher risk of hepatotoxicity. The choice between atorvastatin and simvastatin should consider individual patient risk factors, treatment goals, and potential side effects.
Sources and full results
Most relevant research papers on this topic